Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0018681 (headache)
 56,091 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In recent years a number of new preparations from the group of antiserotonin agents (including cyproheptadine and carbazochrome) as well as beta-adrenergic blocking agents (propranolol) and clonidine have been introduced for prevention of migraine and similar headaches. The efficiency of these drugs was studied in a group of 9 selected cases--adolescents with severe migraine refractory to other methods of treatment. In 7 cases the improvement was noted. The results were compared with own observations on larger groups of adults and data from literature. Too small number of observed patients made impossible definite conclusions. It seems, however that in selected cases the use of these drugs in headaches of adolescents is useful.
 ...
PMID:[New anti-migraine drugs used in the treatment of children and adolescents]. 2 1

In this multi-clinic double-blind study, patients suffering from insomnia were treated with triazolam 0.5 mg (Halcion) or placebo for 14 days. Four investigators treated 239 patients, 122 on triazolam and 117 on placebo. Thirty-nine patients, 10 on triazolam and 29 on placebo, dropped out for ineffectiveness of the medication and 32 patients, 16 in each group, dropped out for side effects. Analysis of pooled efficacy data showed that triazolam was significantly better than placebo on all efficacy parameters measured, including how much the medication helped the patients sleep, onset of sleep, duration of sleep, duration compared to usual, number of nocturnal awakenings, and feeling of restfulness in the morning. Triazolam did not produce evidence of tolerance development after 2 weeks of treatment. The same variety of side effects occurred on each treatment and primarily included drowsiness, grogginess, headaches, impaired coordination nausea, and dizziness.
 ...
PMID:Multi-clinic double-blind comparison of triazolam (Halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia. 2 13


Res Clin Stud Headache 1978
PMID:Headache today--an update by 21 experts. 3 61

The action of tiapride on headaches has been studied in several neurological departments, both in hospitalized and ambulatory patients. A favourable result was obtained in 63,3% of cases (nearly 2 out of 3). A dosage of 400 mg/day is adequate for an opinion of the efficacy of the product to be made, with the average dosage is about 150 mg/day (1/2 table x 3 times a day). Tolerance is excellent. Side-effects, wich were noted in 18% of the patients, consist mainly of somnolence and more rarely akathisia. The good results obtained, and the excellent tolerance, enable its use in debilitated alcoholics, the elderly, and those with vascular disorders.
 ...
PMID:[Therapy of headaches. Apropos of 87 cases]. 3 85

Relationships between the hypothalamus and the pituitary in the aging woman are discussed under the following subheadings: synthesis and release of follicle-stimulating and luteinizing hormones, estrogen receptors, other releasing factors, neurotransmitters, and the mechanisms of hot flushes and migrainoid headaches. The hypothalamus is the main regulator of pituitary function. In the female the hypothalamic-pituitary axis appears to remain functionally intact well into old age.
 ...
PMID:Role of the hypothalamus in the aging woman. 3 41

Headaches are frequent symptoms. Their etiology is due to multiple disturbances of various origins : vascular, digestive, arthrosic, ophthalmologic, ORL. The origin of a headaches is not always quickly revealable to the physician, and the usual analgesics do not soothe the pain. The studied cases prove that most of the headaches are accompanied by dental functional signs, and a panoramic radiography of the jaw can guide the diagnosis. For each studied case, the stomatologic treatment leads to the complete withdrawal of the aching symptom; therefore the presence of the dental etiology in headaches is proved.
 ...
PMID:[Headaches of dental origin (author's transl)]. 3 85

Considered from the point of view of clinical practice, the treatment of chronic headache may be either symptomatic and etiological or physiopathological. Progress in symptomatic treatment depends first on the reasonable and graduated use of pure analgesics, looking out for the toxic side effects of the usual drugs and then the fairly definite efficacy of certain psychotropic drugs. The discovery of an etiology gives a specific dimension to the treatment: either anti-cerebral oedema drugs with above all tetracosactide, a diagnostic test of cerebral tumours, or antidepressor or tranquillizer drugs, depending on the variety of disturbance to be corrected. An attack of migraine always benefits from ergotamine used occasionally and in limited dosage (not more than 6 mg daily or 10 mg per week). For the basic treatment the drugs act mainly peripherally and fairly regularly in the following order: methysergide, beta-blockaders, pizotifene, cyproheptadine, oxetorone. Other drugs have a central effect, Tiapridal, MAO inhibitors which are too often neglected, and clonazepam which is not very easy to use.
 ...
PMID:[The present treatment of headaches (author's transl)]. 3 31

A study of the therapeutic efficacy of tiapride in various neurological disorders was carried out during the period October 1974 to May 1975. Good results were obtained in headaches following lumbar puncture and removal of CSF, and in agitated states, especially those associated with alcoholism.
 ...
PMID:[A therapeutic trial in a neurology department]. 3 33

Typical cases of pollen allergen (hayfever, allergic asthma), together with isolated non-respiratory "equivalent" manifestations (urticaria, eye conditions, headache, etc.), are easy to detect on the basis of skin tests and the clinical history. Such manifestations may also occur in "false pollen allergy", related in most instances by atmospheric moulds (Dematiaceae), sometimes by house dust or dermatophytes (Candida Albicans, Trichophyton sp), by food or by a bacterial infection or allergy. A combination of pollen allergy and false pollen allergy is common. In cases of false pollen allergy the proportion of negative skin reactions would appear to worsen with the repeated use of prolonged action corticosteroid injections, given on a preventive basis. Similarly, these disorders, initially seasonal, change to more chronic manifestations throughout the year. Desensitization with aqueous extracts of allergens ensured the most complete protection against the causes of pollen allergy and false pollen allergy. Allergen extracts percipitated with alun (semi-retard extracts), more effective than tyrosine adsorbates (Pollinex) have the advantage of offering more rapid treatment without the risk of dangerous reactions. The best therapeutic results have obtained over the course of the last ten years, by the authors, combining on each occasion a semi-retard allergen with an aqueous allergen, thereby acquiring the benefit of the adjuvant effect of the first, in a course of ten to fifteen injections per year. Non specific therapy (antihistamines, cromoglycate, theophylline, etc.) retains all of its symptomatic indications. Oral corticosteroid therapy is better metabolized in the organism and has less of a disturbing effect on the circadian rhythm of cortisol, and is hence to be preferred to injections of delyaed action corticosteroid suspensions.
 ...
PMID:[Management in pollinosis and false pollinosis]. 3 22


Headache 1979 May
PMID:The Copenhagen Acute Headache Clinic: organization, patient material and treatment results. 3 64


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>